|Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model.|
|Jump to Full Text|
|PMID: 23532463 Owner: NLM Status: MEDLINE|
|Wear debris-induced osteolysis remains the greatest limitation of long-term success for total joint replacements with ultra-high molecular weight polyethylene (UHMWPE) bearings. To address oxidative degradation post-gamma irradiation, manufacturers are investigating the incorporation of antioxidants into PE resins. Similarly, larger molecular weight monomers have been developed to increase crosslinking and decrease wear debris, and ultimately osteolysis. However, the effects of modifying monomer size, crosslink density, and antioxidant incorporation on UHMWPE particle-induced osteoclastic bone resorption and coupled osteoblastic bone formation have never been tested. Here, we review the field of antioxidant-containing UHMWPE, and present an illustrative pilot study evaluating the osteolytic and osteogenic potential of wear debris generated from three chemically distinct particles (MARATHON®, XLK, and AOX™) as determined by a novel 3D micro-CT algorithm designed for the murine calvaria model. The results demonstrate an approach by which the potential osteoprotective effects of antioxidants in UHMWPE can be evaluated.|
|Justin M Green; Nadim J Hallab; Yen-Shuo Liao; Venkat Narayan; Edward M Schwarz; Chao Xie|
Related Documents :
|25279263 - Fast and accurate estimation of the covariance between pairwise maximum likelihood dist...
25462953 - New approach to phase correction in multi-echo t2 relaxometry.
22775263 - Genetic variation of adaptation to heat stress in two spanish dairy goat breeds.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review|
|Title: Current rheumatology reports Volume: 15 ISSN: 1534-6307 ISO Abbreviation: Curr Rheumatol Rep Publication Date: 2013 May|
|Created Date: 2013-03-27 Completed Date: 2013-09-03 Revised Date: 2014-04-25|
Medline Journal Info:
|Nlm Unique ID: 100888970 Medline TA: Curr Rheumatol Rep Country: United States|
|Languages: eng Pagination: 325 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Antioxidants / chemistry*, pharmacology
Bone Resorption / drug therapy
Disease Models, Animal
Mice, Inbred C57BL
Osteoclasts / drug effects
Osteolysis / chemically induced, prevention & control*
Polyethylenes / adverse effects, chemistry*
Skull / drug effects, radiography
|P30 AR061307/AR/NIAMS NIH HHS; P30 AR061307/AR/NIAMS NIH HHS; P50 AR054041/AR/NIAMS NIH HHS|
|0/Antioxidants; 0/Polyethylenes; 0/ultra-high molecular weight polyethylene|
Journal ID (nlm-ta): Curr Rheumatol Rep
Journal ID (iso-abbrev): Curr Rheumatol Rep
Publisher: Current Science Inc., New York
© The Author(s) 2013
Electronic publication date: Day: 27 Month: 3 Year: 2013
pmc-release publication date: Day: 27 Month: 3 Year: 2013
Print publication date: Month: 5 Year: 2013
Volume: 15 Issue: 5
E-location ID: 325
PubMed Id: 23532463
Publisher Id: 325
|Anti-oxidation Treatment of Ultra High Molecular Weight Polyethylene Components to Decrease Periprosthetic Osteolysis: Evaluation of Osteolytic and Osteogenic Properties of Wear Debris Particles in a Murine Calvaria Model|
|Justin M. GreenAff1Aff2||
|Nadim J. HallabAff3||
|Edward M. SchwarzAff1Aff2Aff5||
Address: +1-585-2753063 +1-585-2751121 Edward_Schwarz@URMC.Rochester.edu
Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 USA
Department of Orthopaedics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 USA
Department of Orthopaedics, Rush University, 1735 W Harrison, Chicago, IL 60612 USA
DePuy, Johnson & Johnson Inc., 700 Orthopaedic Drive, Warsaw, IN 46581 USA
The Center for Musculoskeletal Research, University of Rochester Medical Center, 601 Elmwood Avenue, Box 665, Rochester, NY 14642 USA
Total hip replacement (THR) is most commonly performed for end-stage osteoarthritis, although this procedure is also performed for rarer conditions such as rheumatoid arthritis, avascular necrosis of the hip, and femoral neck fractures. Despite its well-known propensity to generate wear debris and subsequent periprosthetic osteolysis, polyethylene bearing surfaces remain the gold standard for THR based on their consistent results and survivorship of ~85 % after 15 years , and the significant pitfalls of alternative articulation designs (i.e. metal-on-metal and ceramic-on-ceramic) [2••, 3]. Thus, a major focus of ultra high molecular weight polyethylene (UHMWPE) research has been on formulations that minimize host response that leads to aseptic loosening.
One of the consequences of early UHMWPE devices, which are sterilized using high-dose gamma irradiation (25−100 kGy), while exposed to air to also crosslink the polymer chains, is the formation of free radicals that become trapped in the final product . These residual reactive oxygen species (ROS), left unaddressed, cause oxidative degradation as seen in UHMWPE components stored on the shelf for a long time in air-permeable packaging prior to implantation , leading to increased wear and decreased performance in vivo . Additionally, ROS is known to increase the host response to wear debris .
Subsequent improvements in UHMWPE processes introduced temperature-driven manufacturing operations, specifically remelting and annealing, which increases the molecular mobility and facilitates recombination of the free radicals. These additional processes are not without drawbacks, leading either to reduced mechanical properties or only giving a partial protection against oxidation due to ROS [8••]. While annealing methods that heat the UHMWPE to temperatures just below their peak melting point have been adopted to reduce ROS in the manufacturing process, the implants may still be sterilized with gamma irradiation after final packaging, exposing the devices to potentially significant oxidation [9•].
Yet another approach to stabilizing UHMWPE is to provide oxidation resistance without decreasing UHMWPE fatigue strength, by means of the incorporation of antioxidants such as vitamin E into the resin , or by diffusing it into already consolidated and radiated UHMWPE [11•]. This advance adds yet another variable to the chemical composition and molecular response to the irradiation/annealing conditions that can be used to generate novel UHMWPE implants. Since the in vivo wear debris properties of each of these constructs will need to be empirically determined to define their effects on osteoclastic bone resorption (osteolysis) and coupled bone formation (osteogenesis), there is a great need for cost-effective in vitro and in vivo models [12, 13], and the pros and cons of the current murine models have recently been reviewed .
Our research, aimed at understanding the biological responses to wear debris particles, has relied heavily on the murine calvaria model, which was originally developed to study titanium and polymethylmethacrylate particles with histology [15, 16]. Subsequently, this model has been used as a small animal surrogate to study novel interventions for wear debris-induced osteolysis including: bisphosphonates, cyclo-oxygenase inhibitors, TNF and RANKL biologic antagonists, NF-kappa B inhibitors, Jun kinase inhibitors, inhibitors of the NALP3 inflammasome, and adenosine receptor activators [16–26, 27••]. Most recently, this murine calvaria model was modified to study UHMWPE particles , using volumetric micro-CT . Since osteolysis is the result of uncoupled bone resorption, an important component of the murine calvaria model is the robust bone formation that occurs on resorption surfaces within 2 weeks of wear debris implantation , which occurs in the complete absence of osteoclasts . This allows for the analysis of both osteolysis and osteogenesis from longitudinal micro-CT data if a faithful 3D registration algorithm can be developed to quantify the wear debris-induced osteolysis (day 0 calvaria bone volume – day 10 calvaria bone volume) and osteogenesis (day 10 osteoid and under-mineralized bone volume). Here, we describe these methods in a pilot study evaluating the effects of particles from three distinct UHMWPE materials (MARATHON, XLK, and AOX), versus sham surgery and hydrogel (PVA-PAA) particle controls (Table 1), aimed at testing the hypothesis that UHMWPE particles of similar size distribution would illicit similar biological response, despite variations in the starting resin or the presence of the antioxidant.
Particles from three different compositions of UHMWPE (MARATHON, XLK, AOX) were generated from DePuy production barstock lots using high speed cryomilling and cryopulverization (BioEngineering Solutions, Chicago, IL, USA). Particle filtering was used to isolate particles in the 1−10 um range, and they were characterized using low angle laser light scattering (Microtrac-X100,) and scanning electron microscopy with EDS to confirm particle size, shape, and composition. The major differential characteristics of these particles are summarized in Table 2. Particles were EtO sterilized and verified free of endotoxins (<0.01 uE; Kinetic QCL).
All animal studies were performed under protocols approved by the University of Rochester Committee for Animal Resources. Eight-week-old C57B/6 mice were shaved prior to calvaria surgery, and the area was sterilized with 70 % ethanol and iodine. A 0.5– × 0.5-cm area of calvarial bone was exposed by making a midline sagittal incision over the calvaria, leaving the periosteum intact. A low threshold dose of particles known to be required to induce osteolysis (2 mg) or a high dose (5 mg) of MARATHON, XLK, AOX and hydrogel (PVA-PAA) control were spread over the area of each mouse and hydrogel were directly injected onto the calvaria surface (n = 6). Afterwards, the incision was closed with 2.0 interrupted sutures. One assigned group consisting of an incision of only the skin served as a sham surgery control.
Micro-CT scans were performed with a VivaCT40 (ScanCo Medical, Basserdorf, Switzerland) using an isometric resolution of 15 um. Baseline calvaria volume was obtained from in vivo scans on day 0 (before surgery), while the mice were anesthetized with 2 % isofluorine and 1 L/min oxygen. After sacrifice on day 10, the skulls were rescanned with the same parameters. The DICOM micro-CT files were then transferred to Amira v.5.4 (Visage Imaging, San Diego, CA, USA) for quantitative analysis. Quantification of the osteolytic and osteogenic volume was performed as show Fig. 1. Briefly, in vivo micro-CT scans of the calvaria are performed prior to surgical implantation of the wear debris particles (day 0), and ex vivo scans of the calvaria are performed after tissue harvest on day 10. The DICOM files are used to generate an initial 3D image of the calvaria at each time point, and these images are then imported into the Amira program for volumetric registration and analyses. Three distinct tissues types were defined by this process based on their bone mineral density (BMD). In the region of interest (ROI), the original calvarial bone, which has a high BMD (zoom and data window = 1,000–7,000; display and masking = 1,700–7,000), was initially identified. Then an under-mineralized tissue with a lower BMD (zoom and data window = 1,000–3,000; display and masking = 1,000–2,500), was identified within the ROI, which we defined as new bone that formed in response to the wear debris-induced osteolysis. Finally, the unmineralized soft tissue, with a lower BMD, was identified within the ROI between the original calvaria, and the new woven bone was defined as inflammatory tissue. Based on this tissue segmentation, we were able to calculate the volumes and determine the osteolytic versus osteogenic potential of the different particles via liner regression analysis (Fig. 1).
The results from the sham and hydrogel-treated calvaria demonstrated minimal osteolysis and the lack of a significant osteogenesis response in these groups. In contrast, all three particles displayed a significant osteolytic and osteogenic effect vs. sham controls (p < 0.01). Additionally, all three particles demonstrated a dose-dependent effect on both osteolysis and osteogenesis, in which the effects of the 5-mg dose appeared to saturate the host responses. Therefore, lower doses are recommended for future studies. The results from the 2-mg dose produced some interesting trends that warrant further investigation. Of note was that the MARATHON particles induced the smallest osteolytic response among the UHMWPE particles tested, suggesting that at low doses it elicits the best biological response. However, when we analyzed the osteolytic versus osteogenic potential of the particles, the MARATHON particles appear to have uncoupled osteolysis and osteogenesis with a slope = 0.59 (Fig. 1). Thus, this uncoupling highlights the importance of measuring both bone responses when evaluating UHMWPE particles for biocompatibility and toxicity. In contrast, AOX particles slightly favor osteogenesis over osteolysis (slope = 1.27). This suggests that the presence of the antioxidant may produce a more favorable environment for bone formation following wear debris-induced bone resorption.
Under non-pathologic conditions, wear debris-induced bone resorption is coupled to bone formation to prevent osteolysis. This is why only a small fraction of joint replacement patients develop periprosthetic osteolysis and aseptic loosening, while most patients display a linear wear rate over time [30–32]. The theory that aseptic loosing may be due to an uncoupling of osteogenic/osteolytic processes rather than a specific negative wear debris responses is supported by longitudinal volumetric CT analysis of patients with varying degrees of periprosthetic bone loss [31–33]. It is for this reason that we have chosen micro-CT as the primary outcome measure in our preclinical studies, and aimed to develop faithful quantitative measures of coupled vs. uncoupled responses to wear debris. Here, we demonstrate that volumetric longitudinal micro-CT can be used to quantify these events using the murine calvaria model. Using this model, we observed differences in the induced osteolysis. Material factors which may have contributed to these differences include the average molecular weight of the resin (5 vs. 2 million), the presence or absence of the antioxidant, but also the average particle size. In this experiment, attempts were made to control for the particle size, but filtering still produces a distribution of particle sizes with significant overlap, which is an issue that requires attention in the future. Moreover, inclusion of anti-oxidants into the larger particles from lower molecular weight resin without remelting results in UHMWPE (AOX) that has similar osteolytic and osteogenic properties to low dose MARATHON, suggesting a biological effect of the anti-oxidants that compensates for the lack of ROS release from remelting.
One limitation of our pilot study is that the UHMWPE particles differed in more than one variable (Tables 1 and 2). Thus, we are not able to make firm conclusions about the effects of anti-oxidant incorporation. However, it was interesting to see that the AOX particles induced less osteolysis than the XLK particles, and significantly more osteogenesis than the MARATHON (p < 0.05). Formal studies are now planned to directly assess the potential effect of a free radical scavenging antioxidant presence on the overall osteolysis process.
This article is part of the Topical Collection on Osteoarthritis
The authors would like to thank Ryan Tierney and Michael Thullen for technical assistance with the histology and micro-CT analyses, respectively. We also thank Drs. Matthew Dressler and Todd Render for their helpful input. This work was supported by the Orthopaedic Research and Education Foundation; the National Institutes of Health PHS awards P50 AR054041 and P30 AR061307; and DePuy J&J Inc.
Justin M. Green has received research grant support from DePuy J&J.
Nadim J. Hallab has received support for particle production from DePuy J&J and has served as a consultant for DePuy J&J, Smith and Nephew, Medtronic, Orthopedic Analysis LLC, and BioEngineering Solutions.
Yen-Shuo Liao has been employed by DePuy Orthopaedics.
Venkat Narayan has been employed by DePuy Orthopaedics.
Edward M. Schwarz has received research grant support from, served as a consultant for, and received lecturing honoraria from DePuy J&J, and is the founder and president of LAGeT, Inc.
Chao Xie has received research grant support from DePuy J&J.
|1..||Gomez-Barrena E,Medel F,Puertolas JA. Polyethylene oxidation in total hip arthroplasty: evolution and new advancesOpen Orthop JYear: 200931152010.2174/187432500090301011520111694|
|2..||Graves SE,et al. A multinational assessment of metal-on-metal bearings in hip replacementJ Bone Joint Surg AmYear: 201293Suppl 343722262422|
|3..||Garcia-Cimbrelo E,et al. Mittelmeier ceramic-ceramic prosthesis after 10 yearsJ ArthroplastyYear: 1996117738110.1016/S0883-5403(96)80176-88934316|
|4..||Jahan M,et al. A study of long-lived free radicals in gamma-irradiated medical grade polyethleneRadiat Phys ChemYear: 200162141410.1016/S0969-806X(01)00431-5|
|5..||Currier BH, et al. Shelf life and in vivo duration. Impacts on performance of tibial bearings. Clin Orthop Relat Res. 1997;342:111–22.|
|6..||Gomez-Barrena E, et al. Role of polyethylene oxidation and consolidation defects in cup performance. Clin Orthop Relat Res. 1998;352:105–17.|
|7..||Hallab NJ,Jacobs JJ. Biologic effects of implant debrisBull NYU Hosp Jt DisYear: 200967182819583551|
|8..||Atwood SA,et al. Tradeoffs amongst fatigue, wear, and oxidation resistance of cross-linked ultra-high molecular weight polyethyleneJ Mech Behav Biomed MaterYear: 2011410334510.1016/j.jmbbm.2011.03.01221783113|
|9..||Kurtz SM,et al. Mechanical properties, oxidation, and clinical performance of retrieved highly cross-linked Crossfire liners after intermediate-term implantationJ ArthroplastyYear: 2009256142310.1016/j.arth.2009.04.02219520545|
|10..||Lidgren L, et al. The invention relates to a method for the preparation in a reactor of a UHMWPE material doped with an antioxidant, preferably vitamin E. US patent# 6448315. 2002.|
|11..||Oral E,Muratoglu OK. Vitamin E diffused, highly crosslinked UHMWPE: a reviewInt OrthopYear: 2010352152310.1007/s00264-010-1161-y21120476|
|12..||Ingham E,Fisher J. Biological reactions to wear debris in total joint replacementProc Inst Mech Eng HYear: 2000214213710718048|
|13..||Ingham E,Fisher J. The role of macrophages in osteolysis of total joint replacementBiomaterialsYear: 20052612718610.1016/j.biomaterials.2004.04.03515475057|
|14..||Purdue PE,et al. The central role of wear debris in periprosthetic osteolysisHSS JYear: 200621021310.1007/s11420-006-9003-618751821|
|15..||Merkel KD,et al. Tumor necrosis factor-alpha mediates orthopedic implant osteolysisAm J PatholYear: 19991542031010.1016/S0002-9440(10)65266-29916934|
|16..||Schwarz EM,et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysisJ Orthop ResYear: 2000188495510.1002/jor.110018060211192243|
|17..||von Knoch M,et al. The decrease of particle-induced osteolysis after a single dose of bisphosphonateBiomaterialsYear: 2005261803810.1016/j.biomaterials.2004.06.01015576154|
|18..||Tsutsumi R,et al. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CTJ Orthop ResYear: 2008261340610.1002/jor.2062018404739|
|19..||Goater JJ,et al. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysisJ Orthop ResYear: 2002201697310.1016/S0736-0266(01)00083-311918293|
|20..||Zhang X,et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysisJ Bone Miner ResYear: 2001166607010.1359/jbmr.2001.16.4.66011315993|
|21..||Childs LM,et al. Efficacy of etanercept for wear debris-induced osteolysisJ Bone Miner ResYear: 2001163384710.1359/jbmr.2001.16.2.33811204434|
|22..||Childs LM,et al. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesisJ Bone Miner ResYear: 200217192910.1359/jbmr.2002.17.2.19211811549|
|23..||Clohisy JC,et al. NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesisJ Orthop ResYear: 200422132010.1016/S0736-0266(03)00156-614656654|
|24..||Clohisy JC,et al. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysisJ Orthop ResYear: 20062413586510.1002/jor.2018416705717|
|25..||Yamanaka Y,et al. Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclastsJ Orthop ResYear: 20062413495710.1002/jor.2019916732613|
|26..||Burton L,et al. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activationJ Orthop ResYear: 201231738010.1002/jor.2219022933241|
|27..||Mediero A,et al. Adenosine A2A receptor activation prevents wear particle-induced osteolysisSci Transl MedYear: 20124135ra16510.1126/scitranslmed.3003393|
|28..||Taki N,et al. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanismsJ Orthop ResYear: 2005233768310.1016/j.orthres.2004.08.02315734251|
|29..||Kaar SG,et al. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged miceJ Orthop ResYear: 200119171810.1016/S0736-0266(00)00033-411347687|
|30..||Martell JM,Berdia S. Determination of polyethylene wear in total hip replacements with use of digital radiographsJ Bone Joint Surg AmYear: 1997791635419384422|
|31..||Looney RJ,et al. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wearArthritis ResYear: 20024596310.1186/ar38411879538|
|32..||Howie DW,et al. Progression of acetabular periprosthetic osteolytic lesions measured with computed tomographyJ Bone Joint Surg AmYear: 20078918182510.2106/JBJS.E.0130517671023|
|33..||Schwarz EM,et al. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placeboJ Orthop ResYear: 20032110495510.1016/S0736-0266(03)00093-714554218|
Parameters of UHMWPE composition, gamma irradiation, and annealing
|Resin (GUR)||1,050||1,020||1,020 + AO||Poly (vinyl alcohol) and Poly (acrylic acid)|
|Gamma dose||50 kGy||50 kGy||80 kGy||50 kGy|
Physical characteristics of the UHMWPE particles
|Particle size (μm)||2.67||0.48 ~ 23.08||3.9||0.82 ~ 24.94||3.16||0.11 ~ 17.18|
|Aspect ratio||1.73||1.1 ~ 4.63||1.86||1.04 ~ 8.11||1.75||1.07 ~ 16.94|
|Roundness||0.62||0.22 ~ 0.91||0.59||0.12 ~ 0.97||0.64||0.06 ~ 0.94|
|Form factor||0.64||0.12 ~ 0.92||0.57||0.14 ~ 0.88||0.58||0.01 ~ 0.91|
|Perimeter (μm)||11.48||1.78 ~ 138.26||17.59||2.94 ~ 15.50||14.47||0.43 ~ 194.87|
Keywords: Keywords Ultra-high-molecular-weight polyethylene (UHMWPE), Antioxidant, Wear debris, Osteolysis, Mouse model, Murine model, Treatment, Osteoarthritis.
Previous Document: Complex mullerian duct anomaly in a young female with primary amenorrhoea, infertility, and chronic ...
Next Document: A Reliable Statistical Method to Detect Eyeblink-Artefacts from Electroencephalogram Data Only.